May 14, 2019

has announced a shift in business strategy and the terms of a proposed new financing. FCOL has entered into a non-binding letter of intent with Critical Mass Industries LLC DBA Good Meds pursuant to which FCOL will acquire the management assets related to dispensing, cultivation and extraction as well as the brand assets of Good Meds, which includes BOSM Labs, in exchange for US $1,999,770 and 15,053,233 shares of common stock. FCOL has also entered into a non-binding letter of intent with General Extract LLC DBA General Extract. The transactions are expected to close in the second quarter of 2019. In connection with these acquisitions, FCOL will dispose of its Colombian businesses and concentrate on the development of a nationwide network of medical marijuana dispensaries and related businesses in the United States, where legally permitted, with a focus on both THC-dominant and CBD-dominant cannabis manufacturing, distribution and sales. "These acquisitions along with the shift in business strategy mark the beginning of FCOL as a U.S. cannabis industry operator. The addition of the Good Meds team and brands, with their decade-long legacy as successful cannabis operators, will give us the head start we will need as a U.S.-based publicly traded cannabis enterprise. We look forward to sharing many new developments in the near future," said Chris Hansen, founding CEO of FCOL. First Colombia Development Corp. also announced the terms of a proposed private placement of FCOL's common stock in a non-brokered transaction. Under the terms of the private placement, FCOL intends to offer up to US $7 million in shares of common stock at a purchase price of US $0.50 per share. As of the date of this release, the company has not entered into any binding agreements with respect to the sale of the shares; the company has had preliminary discussions with proposed investors. While the company is confident that the placement will be successful, there can be no assurance that the financing will close or that the terms will not be modified. The offering will be made exclusively to accredited investors pursuant to exemptions from registration under the Securities Act of 1933. John Knapp, founder and CEO of Good Meds, stated: "The entire team at Good Meds is extremely excited about the partnership with FCOL. We have spent the last decade positioning the company and its brands for this moment, and we finally have the right partners to help us realize our dream of building a national dispensary network that leverages the Good Meds brands and product portfolio." This press release is not an offer of securities, or a solicitation for purchase, subscription or sale of securities in the United States of America or in any other jurisdiction in which it would be unlawful to do so. Toronto, ON, May 14, 2019 – PRESS RELEASE –  The Green Organic Dutchman Holdings Ltd.  has announced that it has obtained approval from Health Canada, under the Cannabis Regulations, to expand operations into its new state-of-the-art building located in Hamilton, Ontario. The 20,000-square-foot indoor facility is going to be used for cannabis cultivation; planting will start in the coming weeks. “This is yet another important milestone for our team as we continue to ramp up production with a focus on executional excellence,” commented Brian Athaide, CEO of TGOD. “We have pioneered the concept of sustainably growing all-natural, certified organic cannabis at scale. The product we are able to offer Canadians is clean, pesticide-free and undeniably premium.” The newly built facility is the second of three buildings at TGOD’s Hamilton site, which will have a total size of 166,000 square feet when all are completed later this summer, and an annual production capacity of 17,500 kgs. The company is also seeking an eGMP certification for this facility in order to allow for global exports, as laws and regulations permit. PRESS RELEASE - The Washington State Liquor and Cannabis Board (WSLCB) announced Thursday, May 2, that a new, mandatory sign must be posted in all licensed establishments effective June 1 (view the bulletin: Notice May 2 ). LCB and the Washington State Department of Health (DOH) created the mandatory warning sign to educate the public about the harms of cannabis use during pregnancy and breastfeeding. Starting June 1, 2019, marijuana retail shops are required to prominently display the sign. You may download and print the sign here . For questions regarding the signage, please contact WSLCB Rules Coordinator Kathy Hoffman at 360-664-1622 or Katherine.Hoffman@lcb.wa.gov or contact your enforcement officer. Toronto, Ontario – May 9, 2019 – PRESS RELEASE – Canopy Rivers Inc. has announced that its portfolio company PharmHouse Inc. has entered into a second offtake agreement with Canopy Growth Corporation for the purchase of cannabis from its 1.3-million-square-foot greenhouse facility upon licensing. The agreement commits an additional 20 percent of PharmHouse’s flowering space to Canopy Growth for the next three years, in addition to the 10 percent that was originally committed in May 2018. The agreement provides for the delivery to Canopy Growth of a minimum of 25,000 kg of cannabis per year and a maximum of 45,000 kg of cannabis per year. “PharmHouse continues to show tremendous progress at the facility, and the joint venture is quickly developing as a key pillar for value creation and synergy within the Canopy Rivers portfolio ecosystem,” said Olivier Dufourmantelle, chief operating officer of Canopy Rivers. “Thanks to the collaborative contributions of our joint venture partners, the ongoing support and guidance of Canopy Rivers, and the strategic insight of Canopy Growth throughout the licensing process, we are excited to announce an incremental supply partnership that mutually benefits all three parties.” This new supply arrangement provides PharmHouse with additional revenue visibility and financial de-risking for a significant portion of the expected production from the flagship facility. Canopy Rivers holds a 49 percent equity interest in the PharmHouse joint venture and has played an active role in sourcing and negotiating production and supply agreements, which now cover approximately 50 percent of expected annual output. The incremental 50 percent of output remains unencumbered for the development of PharmHouse’s own suite of brands and products. “This offtake agreement represents a significant step forward for PharmHouse. By effectively committing and selling 50 percent of our near-term cannabis production, we favorably position PharmHouse for the development of a proprietary suite of products and brands and/or the pursuit of incremental contract manufacturing agreements,” said Tony Abbas, general manager of PharmHouse. “The fact that we are executing yet another agreement with an industry titan like Canopy Growth sends a strong signal about the quality of our operations and the confidence in our team’s ability to deliver.” The 1.3-million-square-foot facility in Leamington represents the first stage of a planned global strategic relationship between Canopy Rivers and its PharmHouse joint venture partner, a company formed by the leading principals and operators of a North American agriculture conglomerate. The parties seek to leverage their relationship networks and respective strengths in cannabis, global commercial agriculture, marketing, and distribution to pursue regulated cannabis opportunities together on a global scale. NEW YORK, May 13, 2019 (GLOBE NEWSWIRE) -- PRESS RELEASE -- Acreage Holdings, Inc. has announced it has entered into a Letter of Intent with GreenAcreage Real Estate Corp. (GARE), a newly formed REIT, negotiated at arm’s length, under which GARE would purchase and lease back to Acreage cannabis-related real estate assets. GARE is externally managed by GreenAcreage Management LLC, an entity in which Acreage holds a 20-percent interest and in which its CEO has invested. The provisions of the Letter of Intent state that GARE would, upon the financing of GARE, purchase properties identified by both parties for values to be mutually agreed upon, fund or reimburse Acreage for real estate improvements and lease said identified properties back to Acreage in accordance with negotiated terms. Acreage would also grant GARE a right of first offer to assume Acreage’s position as a purchaser of a pipeline of properties over the next three years. GARE will operate initially as an externally-managed company, advised by GreenAcreage, and will remain independent from Acreage. GARE boasts a highly respected and experienced leadership team featuring Executive Chairman Gordon DuGan, Vice Chairman and Founder David Carroll and Chief Executive Officer Katie Barthmaier.